Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: Better antibody increase from booster dose of the Edmonston-Zagreb vaccine

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 1951-1959

  Garly, May Lill ^a,b   Balé, Carlitos ^a   Martins, Cesário L ^a   Monteiro, Mario ^a,c   George, Elishia ^d   Kidd, Michael ^d   Dias, Francisco ^c   Aaby, Peter ^a,b   Whittle, Hilton C ^d  

^a Projecto De Saúde De Bandim ^*  (Guinea-Bissau)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^c Lab Nac de Saude Pub   (Guinea-Bissau)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Africa; Boosting; Guinea Bissau; Measles antibodies; Two dose schedule

Indexed keywords

MATERNAL ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; GUINEA-BISSAU; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVACCINATION;

AGE FACTORS; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GUINEA-BISSAU; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS;

EID: 0035961462     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00431-X     Document Type: Article

References (41)

1. Two-dose measles vaccination schedules
2. Failure of antibody response following measles vaccination
3. Conversion rates and side effects following vaccination with three different batches of the 'Schwarz' measles strain
4. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine
5. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection
6. Immunization of young infants with Edmonston-Zagreb measles vaccine
7. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months
8. Immunization of 6-month-old infants with different doses of Edmonston-Zagreb and Schwarz vaccines
9. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from 4 months of age
10. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants
11. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants
12. Vaccination of Saudi children against measles with Edmonston-Zagreb
13. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine
14. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire
15. Comparison of Edmonston-Zagreb, Connaught and Schwarz measles vaccines in Cameroonian infants aged 3-8 months
16. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months
17. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: A randomised trial
18. The epidemiology of measles: 30 Years of vaccination
19. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: Antibody response and side-effects
20. Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization
21. Measles immunity after revaccination: Results in children vaccinated before 10 months of age
22. Inadequate immunity to measles in children vaccinated at an early age: Effect of revaccination
23. Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by ELISA
24. Early two-dose measles vaccination schedule in Guinea-Bissau: Good protection and coverage in infancy
25. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine
26. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal
27. Titration of virus in monolayer cell cultures, TCID50 end points
28. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants
29. Cellular immunity in measles vaccine failure: Demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination
30. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children
31. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants
32. Success of the Edmonston-Zagreb measles virus as a booster vaccine
33. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains
34. Generation of defective interfering particles by two vaccine strains of measles virus
35. Poor serological responses 5-7 years after immunization with high and standard titre measles vaccines
36. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa
37. Waning of vaccine-induced immunity: Is it a problem in Africa?
38. Edmonston-Zagreb measles vaccine: A good vaccine with an image problem
39. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age
40. Non-specific beneficial effect of measles immunisation: Analysis of mortality studies from developing countries